Genentech is accepting proposals for the 2024 Health Equity Innovation Fund to measurably and sustainably close racial and ethnic inequities in healthcare.
Donor Name: Genentech
State: All States
County: All Counties
Type of Grant: Grant
Deadline: 04/15/2024
Size of the Grant: $500,000 to $1 million
Grant Duration: 3 Years
Details:
Through the 2024 Innovation Fund, Genentech will make groundbreaking investments that help to achieve a long-term future where:
- All patients—especially those marginalized by the healthcare system—define and attain their highest levels of health supported by a system that is accountable for delivering access to high-quality competent care
- The medical and scientific workforce is diverse, inclusive, thriving, and accountable to the needs of all patients.
Genentech is specifically seeking proposals that address inequities in patient outcomes and healthcare workforce experiences across at least one of the therapeutic areas below:
- Neuroscience and Brain Health, including but not limited to multiple sclerosis
- Oncology, including but not limited to Breast, Lung, & hepatocellular carcinoma (HCC)
- Ophthalmology, including but not limited to diabetic macular edema
- Cardiovascular and Metabolic Disease, including but not limited to diabetes, hypertension, and obesity
The Genentech Innovation Fund invests in bold ideas and the people who power them. These grants support individuals, organizations and communities coming together to address inequity. Grants can be used to develop and test novel ideas or tools, implement demonstration projects, resource collaboration and partnership, and support research that goes beyond “studying the problem” or building capacity within a single institution.
Funding Information
Genentech will fund up to $750k per project but they welcome a range of grant requests. Please note that Genentech will not be funding planning grants. Grant periods are flexible, though generally range from 18 months to 3 years.
Eligibility Criteria
Applicants must be recognized by the IRS as a tax exempt, public charity under sections 501(c)(3) and 501(c)(6) of the Internal Revenue Code or be a U.S. governmental organization (such as public schools, public colleges and universities, public hospitals, and federally recognized Indian tribal governments).
In order to be eligible for this type of funding, the funding must not be used for:
- Projects taking place outside of the United States
- The purpose of developing clinical practice guidelines (e.g., statements that include recommendations intended to help practitioners make appropriate health care decisions for specific clinical conditions)
- Religious purposes
- Promotion of a Genentech or Roche product or to influence formulary decisions
- Research involving or undertaken in relation to Genentech or Roche products (whether investigational and/or approved for other uses)
- Accredited Independent Medical Education
- Proposal budget cannot exceed 33% of organizational budget and indirect administrative overhead costs cannot exceed more than 25% of the grant amount.
For more information, visit Genentech.
